GBA1 and Parkinson disease: However, CFS samples from LRRK2 PD patients (78%) showed an elevated α-syn positivity, only exceeded by CSF samples from DLB (100%) or PD (93%) patients carrying GBA1 mutations (Brockmann et al., 2021).